V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20153114 | 20087848 | 1.59 | 54 | 03 | 2018-02-17 | 2018-02-17 | Obinutuzumab | 02 | N | CARBOPLATIN + FLUOROURACIL | 100462830 |
| 20153263 | 20087849 | 1.78 | 89.2 | Palliative (P) | 2016-04-04 | 2016-04-11 | CHOP - 21 days | 2 | N | HEPATOBLASTOMA VHR BLOCK A CISPLATIN/DOX | 101527211 |
| 20153311 | 20087850 | null | 83.2 | 03 | null | 2017-10-20 | ACTICCA-1 Trial | 01 | N | CHOP R | 101013364 |
| 20153320 | 20087851 | 1.65 | 56.6 | 03 | 2020-01-10 | 2020-01-23 | CARBOPLATIN + GEMCITABINE | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101387943 |
| 20153459 | 20087852 | null | null | Palliative (P) | 2019-03-06 | 2019-04-07 | ECarboX | null | N | ECARBOX | 100691069 |
| 20153571 | 20087854 | 0 | 0 | Adjuvant (A) | 2020-11-10 | 2020-11-11 | CAV | N | null | CISPLATIN + FLUOROURACIL + RT | 101299683 |
| 20153599 | 20087855 | 0 | 50.4 | null | 2016-05-11 | 2016-05-18 | FOXTROT TRIAL | 02 | N | PLATFORM TRIAL | 101454725 |
| 20153603 | 20087856 | 1.68 | 82.7 | 03 | 2019-11-17 | 2020-01-19 | Hydroxycarbamide | 02 | N | POMALIDOMIDE | 100824332 |
| 20153636 | 20087857 | 1.55 | 112 | Palliative (P) | 2018-03-01 | 2018-03-01 | Panitumumab | 01 | N | PANITUMUMAB | 101116522 |
| 20153723 | 20087858 | 1.64 | 86.3 | Palliative (P) | 2017-05-02 | 2017-05-02 | PACLITAXEL + TRASTUZUMAB | 01 | N | ESPAC TRIAL | 100127019 |
| 20154014 | 20087859 | 1.71 | 66.5 | Palliative (P) | 2017-12-24 | 2017-12-29 | EEF or EOF | 99 | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 100727334 |
| 20154024 | 20087860 | 1.7 | 65 | Palliative (P) | 2019-10-26 | 2019-11-02 | Sunitinib | 02 | N | CARBOPLATIN + DOCETAXEL | 101388079 |
| 20154032 | 20087861 | 1.71 | 43.6 | Palliative (P) | 2020-07-24 | 2020-07-31 | SCOPE 2 TRIAL | N | N | BORTEZOMIB + MELPHALAN | 100813637 |
| 20154061 | 20087862 | 1.83 | 74.4 | Neo-adjuvant (N) | 2021-07-26 | 2021-08-09 | Capecitabine + Streptozocin | 02 | Y | FCARBOST | 100648770 |
| 20154104 | 20087863 | 1.77 | 78.8 | 03 | 2017-01-15 | 2017-01-22 | Irinotecan | 02 | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 100857142 |
| 20154174 | 20087864 | 1.62 | 84.5 | Palliative (P) | 2019-04-15 | 2019-05-06 | Letrozole + Ribociclib | 02 | null | CHLVPP | 101021004 |
| 20154230 | 20087867 | 1.78 | 87 | Palliative (P) | 2016-10-21 | 2016-11-06 | Fluorouracil + Folinic + RT Bossett | 02 | N | CISPLATIN + FLUOROURACIL + RT | 100416864 |
| 20154246 | 20087868 | 1.5 | 60.4 | 03 | 2019-09-11 | 2019-10-10 | TCX | 02 | N | DOXORUBICIN + IFOSFAMIDE | 100290184 |
| 20154263 | 20087869 | 1.77 | 63.9 | 03 | 2019-12-19 | 2019-12-27 | Fluorouracil + Folinic + RT Bossett | 02 | N | DOCETAXEL | 100523959 |
| 20154286 | 20087870 | 1.74 | 75.8 | 03 | 2017-12-14 | 2017-12-14 | BORTEZOMIB + THALIDOMIDE | 02 | N | MITOMYCIN | 100741118 |
| 20154366 | 20087871 | 1.59 | 67.2 | Palliative (P) | null | 2019-04-27 | PEMBROLIZUMAB | null | N | PANITUMUMAB | 101140001 |
| 20154448 | 20087873 | 1.75 | 77 | Adjuvant (A) | 2018-01-04 | 2018-01-11 | Capecitabine + Streptozocin | 02 | N | ARISTOTLE TRIAL | 100917844 |
| 20154494 | 20087874 | 1.7 | 115 | Palliative (P) | null | 2020-01-17 | EEF or EOF | N | N | EOF | 100960279 |
| 20154783 | 20087875 | 0 | 0 | Palliative (P) | 2017-06-15 | 2017-07-09 | CISPLATIN + RT | 01 | N | ACTICCA-1 TRIAL | 101509695 |
| 20154786 | 20087876 | 1.75 | 78 | 03 | 2015-05-14 | 2015-05-30 | Raltitrexed | 02 | N | RALTITREXED | 100122535 |
| 20154805 | 20087877 | 1.7 | 71 | Adjuvant (A) | 2018-08-14 | 2018-08-15 | ACTICCA-1 Trial | 02 | N | NIVOLUMAB | 101820297 |
| 20154905 | 20087878 | 1.59 | 84.3 | Palliative (P) | 2018-07-12 | 2018-08-09 | Paclitaxel albumin (Abraxane) 7 day | 02 | Y | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101838371 |
| 20154944 | 20087879 | 1.84 | 102 | Adjuvant (A) | null | 2020-02-14 | Cisplatin + Fluorouracil + RT 5day | 99 | N | IBRUTINIB | 101174419 |
| 20155154 | 20087880 | null | null | null | 2018-11-20 | 2018-11-22 | Carboplatin + Pemetrexed | 02 | N | CISPLATIN + FLUOROURACIL + RT | 100514947 |
| 20155311 | 20087881 | 1.55 | 56.6 | 03 | 2021-12-15 | 2022-01-05 | SCOPE 2 TRIAL | 02 | N | MITOMYCIN | 101600579 |
| 20155386 | 20087882 | null | null | Palliative (P) | 2017-09-24 | 2017-09-24 | Everolimus 10mg | 02 | N | NOT MATCHED | 101304553 |
| 20155405 | 20087883 | 1.67 | 95 | null | 2017-06-01 | 2017-06-03 | Docetaxel | 02 | N | BALLAD TRIAL | 101251792 |
| 20155475 | 20087884 | 1.8 | 96.5 | Palliative (P) | 2017-04-12 | 2017-04-18 | PACLITAXEL | 02 | N | EVEROLIMUS | 101204404 |
| 20155594 | 20087885 | 1.69 | 90.6 | Palliative (P) | 2018-08-06 | 2018-08-11 | ECarboX | 99 | N | BLEOMYCIN + CYCLOPHOSPHAMIDE + ETOPOSIDE + MITOXANTRONE + PROCARBAZINE + VINBLASTINE | 100368230 |
| 20155694 | 20087887 | null | null | null | 2020-01-30 | 2020-01-30 | FLUOROURACIL + PEGINTERFERON ALFA | 02 | N | MITOMYCIN | 100475905 |
| 20155704 | 20087888 | 1.65 | 35.7 | null | 2018-10-03 | 2018-10-06 | BCG Intravesical | 02 | N | CARBOPLATIN + FLUOROURACIL | 101430895 |
| 20155759 | 20087889 | 1.59 | 77 | Palliative (P) | null | 2019-11-07 | CARBOPLATIN + RT | 01 | N | CISPLATIN + FLUOROURACIL + RT | 101793421 |
| 20155799 | 20087891 | 1.72 | 54.8 | null | 2019-03-23 | 2019-04-10 | Pentostatin | 02 | N | ABIRATERONE | 100849740 |
| 20155807 | 20087892 | 1.65 | 72.25 | Adjuvant (A) | null | 2016-05-04 | ECarboX | null | N | OXALIPLATIN | 100836752 |
| 20155848 | 20087893 | 1.58 | 87.52 | 03 | 2015-12-11 | 2015-12-26 | CHOP - 21 days | 02 | N | AZACITIDINE + VENETOCLAX | 101807614 |
| 20155960 | 20087894 | 1.71 | 62.5 | 03 | null | 2019-04-21 | Paclitaxel albumin (Abraxane) 21day | 2 | N | BALLAD TRIAL | 100561593 |
| 20156050 | 20087897 | 1.7 | 68.6 | 03 | 2018-03-25 | 2018-04-01 | HEP SIOPEL 6 Cisplatin | 02 | N | CARBO + FLUOROURACIL | 101822722 |
| 20156052 | 20087898 | 1.54 | 66.7 | 03 | 2018-06-10 | 2018-06-24 | Melphalan IV High dose | 01 | N | RALTITREXED | 100769542 |
| 20156077 | 20087899 | 1.72 | 7.7 | 03 | 2017-10-13 | 2017-10-17 | Trifluridine + Tipiracil | 02 | N | EOF | 101081415 |
| 20156078 | 20087900 | 1.65 | 60.8 | 03 | 2018-02-18 | 2018-02-26 | Cisplatin + Radiotherapy | null | N | SCOPE2 TRIAL | 100841349 |
| 20156098 | 20087901 | 0 | 11.1 | Palliative (P) | 2021-01-31 | 2021-02-21 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | CISPLATIN + FLUOROURACIL + MITOMYCIN | 101321781 |
| 20156138 | 20087902 | 1.72 | 70 | 03 | null | 2017-07-03 | null | N | N | CYCLOPHOSPHAMIDE + THALIDOMIDE | 101632907 |
| 20156201 | 20087903 | 1.73 | 62.3 | Palliative (P) | 2018-11-14 | 2018-11-21 | Capecitabine + Streptozocin | N | N | IDELALISIB | 100502263 |
| 20156561 | 20087905 | 1.44 | 44 | Palliative (P) | 2017-04-23 | 2017-05-05 | CISPLATIN + FLUOROURACIL + RT | 02 | N | GEMCITABINE + PACLITAXEL | 100023379 |
| 20156652 | 20087906 | 1.53 | 96 | 03 | 2019-03-02 | 2019-03-14 | IDELALISIB + RITUXIMAB | 02 | N | ESPAC TRIAL | 101151007 |